PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för XMD-17-51. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

6 hits

Bibliografisk träff 2024-08-21

Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer.

Rinderle CH, Baker CV, Lagarde CB, Nguyen K, Al-Ghadban S, Matossian MD, Hoang VT, Martin EC, Collins-Burow BM, Ali S, Drewry DH, Burow ME, Bunnell BA.

Anticancer Drugs · research support, non-u.s. gov't; research-article; journal article · DOI 10.1097/cad.0000000000001658

Bibliografisk träff 2023-10-30

Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors.

Reinecke M, Brear P, Vornholz L, Berger BT, Seefried F, Wilhelm S, Samaras P, Gyenis L, Litchfield DW, Médard G, Müller S, Ruland J, Hyvönen M, Wilhelm M, Kuster B.

Nat Chem Biol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41589-023-01459-3

Bibliografisk träff 2021-03-08

XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression.

Yang WQ, Zhao WJ, Zhu LL, Xu SJ, Zhang XL, Liang Y, Ding XF, Kiselyov A, Chen G.

Front Pharmacol · research-article; journal article · DOI 10.3389/fphar.2021.603453

Bibliografisk träff 2021-01-08

The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification.

Wells CI, Al-Ali H, Andrews DM, Asquith CRM, Axtman AD, Dikic I, Ebner D, Ettmayer P, Fischer C, Frederiksen M, Futrell RE, Gray NS, Hatch SB, Knapp S, Lücking U, Michaelides M, Mills CE, Müller S, Owen D, Picado A, Saikatendu KS, Schröder M, Stolz A, Tellechea M, Turunen BJ, Vilar S, Wang J, Zuercher WJ, Willson TM, Drewry DH.

Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms22020566

Bibliografisk träff 2020-12-04

Optimization of WZ4003 as NUAK inhibitors against human colorectal cancer.

Yang H, Wang X, Wang C, Yin F, Qu L, Shi C, Zhao J, Li S, Ji L, Peng W, Luo H, Cheng M, Kong L.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2020.113080

Bibliografisk träff 2014-01-01

Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases.

Banerjee S, Buhrlage SJ, Huang HT, Deng X, Zhou W, Wang J, Traynor R, Prescott AR, Alessi DR, Gray NS.

Biochem J · research support, non-u.s. gov't; research-article; journal article · DOI 10.1042/bj20131152